These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21314208)

  • 1. Prostatic assessment in rats after bilateral orchidectomy and calcitonin treatment.
    Al-Shahat AR; Shaikh MA; Elmansy RA; Shehzad K; Kaimkhani ZA
    Endocr Regul; 2011 Jan; 45(1):29-36. PubMed ID: 21314208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The palliative effect of bilateral orchiectomy in metastatic cancer of the prostate].
    Hansen PM; Lauritsen KB
    Ugeskr Laeger; 1990 Feb; 152(7):473-5. PubMed ID: 1689915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased concentration of prostatic inhibin following orchidectomy in rat.
    Mundle S; Sheth A; Sheth N
    Indian J Exp Biol; 1990 Oct; 28(10):911-4. PubMed ID: 2279763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of chlormadinone acetate-pellet implantation and orchidectomy on benign prostatic hypertrophy in the dog.
    Kawakami E; Tsutsui T; Shimizu M; Orima H; Fujita M; Ogasa A
    Int J Androl; 1995 Oct; 18(5):248-55. PubMed ID: 8567095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citrus juice modulates bone strength in male senescent rat model of osteoporosis.
    Deyhim F; Garica K; Lopez E; Gonzalez J; Ino S; Garcia M; Patil BS
    Nutrition; 2006 May; 22(5):559-63. PubMed ID: 16472977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoporosis after orchiectomy for prostate cancer.
    Daniell HW
    J Urol; 1997 Feb; 157(2):439-44. PubMed ID: 8996327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rat prostatic weight regression in reaction to ketoconazole, cyproterone acetate, and RU 23908 as adjuncts to a depot formulation of gonadotropin-releasing hormone analogue.
    Lamberts SW; Uitterlinden P; de Jong FH
    Cancer Res; 1988 Nov; 48(21):6063-8. PubMed ID: 2844399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptides bombesin and calcitonin inhibit apoptosis-related elemental changes in prostate carcinoma cell lines.
    Salido M; Vilches J; López A; Roomans GM
    Cancer; 2002 Jan; 94(2):368-77. PubMed ID: 11900223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of estradiol-17beta, testosterone and a black cohosh preparation on bone and prostate in orchidectomized rats.
    Seidlová-Wuttke D; Jarry H; Pitzel L; Wuttke W
    Maturitas; 2005 Jun; 51(2):177-86. PubMed ID: 15917159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of bone density loss and bone turnover in patients with hormone-sensitive prostate cancer and receiving zoledronic acid.
    Ryan CW; Huo D; Bylow K; Demers LM; Stadler WM; Henderson TO; Vogelzang NJ
    BJU Int; 2007 Jul; 100(1):70-5. PubMed ID: 17552955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antinociceptive effect of calcitonin].
    Takayama B; Kikuchi S; Konno S; Sekiguchi M
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():391-5. PubMed ID: 18161138
    [No Abstract]   [Full Text] [Related]  

  • 12. The treatment of advanced prostatic carcinoma with total androgenic blockade using bilateral orchidectomy and flutamide: experience at the National Cancer Institute in Mexico.
    Mendoza-Valdés A; Ocampo-del-Carpio O; De-la-Garza J
    Semin Oncol; 1991 Oct; 18(5 Suppl 6):19-20. PubMed ID: 1948118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Slow zoledronic acid releasing testis prostheses in the treatment of prostate cancer patients with bone metastases.
    Serefoglu EC; Balbay MD
    Med Hypotheses; 2009 Sep; 73(3):387-8. PubMed ID: 19403241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent insights into mechanisms for analgesic effect by calcitonin].
    Ito A; Furue H; Yoshimura M
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():386-90. PubMed ID: 18161137
    [No Abstract]   [Full Text] [Related]  

  • 15. A stroma targeted therapy enhances castration effects in a transplantable rat prostate cancer model.
    Johansson A; Jones J; Pietras K; Kilter S; Skytt A; Rudolfsson SH; Bergh A
    Prostate; 2007 Nov; 67(15):1664-76. PubMed ID: 17854058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flutamide versus orchidectomy in the treatment of metastatic prostate carcinoma.
    Boccon-Gibod L; Fournier G; Bottet P; Marechal JM; Guiter J; Rischman P; Hubert J; Soret JY; Mangin P; Mallo C; Fraysse CE
    Eur Urol; 1997; 32(4):391-5; discussion 395-6. PubMed ID: 9412794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of prostate atrophy after glandular botulinum neurotoxin type a injection: an experimental study in the rat.
    Silva J; Pinto R; Carvallho T; Coelho A; Avelino A; Dinis P; Cruz F
    Eur Urol; 2009 Jul; 56(1):134-40. PubMed ID: 18649990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of coumarin on the normal rat prostate and on the R-3327H prostatic adenocarcinoma.
    Omarbasha B; Fair WR; Heston WD
    Cancer Res; 1989 Jun; 49(11):3045-9. PubMed ID: 2720665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoporosis in men treated with androgen deprivation therapy for prostate cancer.
    Ross RW; Small EJ
    J Urol; 2002 May; 167(5):1952-6. PubMed ID: 11956415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-resistance reduces botulinum neurotoxin-type A induced prostatic atrophy and apoptosis in rats.
    Vikram A; Jena G; Ramarao P
    Eur J Pharmacol; 2011 Jan; 650(1):356-63. PubMed ID: 20940009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.